Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Trulieve Cannabis's Revenue for the
three
months ended in Mar. 2026 was €248 Mil. Trulieve Cannabis's average Accounts Receivable for the
three
months ended in Mar. 2026 was €11 Mil.
Hence, Trulieve Cannabis's Receivables Turnover for the
three
months ended in Mar. 2026 was 23.49.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Trulieve Cannabis Receivables Turnover Related Terms
Trulieve Cannabis Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Trulieve Cannabis's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:T0A vs ANIP, XERS, HROW: Receivables Turnover Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Trulieve Cannabis's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Trulieve Cannabis Receivables Turnover vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Trulieve Cannabis's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Trulieve Cannabis's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Trulieve Cannabis (FRA:T0A) has a Receivables Turnover of 23.49 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Trulieve Cannabis and its competitors. According to the industry distribution chart, Trulieve Cannabis ranks #9 out of 950 companies in the Drug Manufacturers industry, placing it in the top 0.90000000000001%.
Is Trulieve Cannabis' Receivables Turnover too high?
Trulieve Cannabis' current Receivables Turnover is 23.49. The Drug Manufacturers industry median Receivables Turnover is 5.06. Trulieve Cannabis' value of 23.49 is 364.2% above this industry median. Based on the distribution chart, Trulieve Cannabis ranks #9 out of 950 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Trulieve Cannabis has a GF Score™ of 65/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Trulieve Cannabis' Receivables Turnover compare to ANIP and XERS?
According to the Drug Manufacturers industry distribution chart, Trulieve Cannabis ranks #9 out of 950 companies for Receivables Turnover. This places Trulieve Cannabis in the top 1% of its industry — outperforming the majority of peers. The industry median Receivables Turnover is 5.06. Trulieve Cannabis' value of 23.49 is 364.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Drug Manufacturers company?
The median Receivables Turnover among Drug Manufacturers companies is 5.06, based on 950 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Trulieve Cannabis's current Receivables Turnover of 23.49 is 364.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Trulieve Cannabis and its competitors. For the Drug Manufacturers industry, the median Receivables Turnover is 5.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Trulieve Cannabis's current Receivables Turnover is 23.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Trulieve Cannabis stock overvalued right now?
Based on GuruFocus' analysis, Trulieve Cannabis (FRA:T0A) is currently considered Significantly Overvalued. The stock's GF Value™ is €4.78, compared to a current price of €7.19 — trading 50.4% above its estimated fair value. The current Receivables Turnover is 23.49 and 364.2% above the Drug Manufacturers industry median of 5.06. Trulieve Cannabis' overall GF Score™ is 65/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Trulieve Cannabis (FRA:T0A), the current Receivables Turnover is 23.49 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Trulieve Cannabis (FRA:T0A) Overvalued in 2026?
Based on GuruFocus' analysis, Trulieve Cannabis stock appears to be overvalued.
The current stock price of €7.19 is trading 50.4% above its estimated GF Value™ of €4.78.
GuruFocus considers Trulieve Cannabis to be Significantly Overvalued.
Key valuation signals for FRA:T0A:
Receivables Turnover: 23.49
GF Value™: €4.78 vs. price of €7.19 (50.4% above fair value)
Industry Position: 364.2% above the Drug Manufacturers median (#9 of 950)
No single metric tells the full story. See the FRA:T0A stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Trulieve Cannabis Corp is a vertically integrated cannabis company that grows, produces, and sells cannabis products. It has licenses to operate in Arizona, Colorado, Connecticut, Florida, Georgia, Maryland, Ohio, Pennsylvania, and West Virginia, where it sells medical cannabis products. In addition, the company sells cannabis products for adult use in Arizona, Colorado, Connecticut, Maryland, and Ohio. The firm's operations are substantially located in Florida and, to a lesser extent, in Arizona and Pennsylvania.
65GF Score
Get the complete analysis for FRA:T0A
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:T0A has been successfully added to your 
